BackVallon Pharmaceuticals Overview

Vallon Pharmaceuticals Receivables

Track Vallon Pharmaceuticals's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average

Loading

Vallon Pharmaceuticals Receivables History

Loading

Vallon Pharmaceuticals vs. peers: Receivables Comparison

Loading

Vallon Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Vallon Pharmaceuticals (VLON) FAQ

Vallon Pharmaceuticals posts a receivables of $0 as of March 2025. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Vallon Pharmaceuticals's receivables was $0. The latest reading is $0 (period ending March 2025). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Vallon Pharmaceuticals's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for VLON's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Vallon Pharmaceuticals's other metric pages and overview cover the third.

Judging Vallon Pharmaceuticals against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in receivables easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.